Implications of the Patient Protection and Affordable Care Act for Hematologists
Dr Lawrence A. Solberg delivered the keynote address at Cytopenias & Hemostasis in 2011, in which he discussed the implications of the healthcare reform act for the practice of hematology. The address was captured live in Chicago on May 5, 2011, and is presented here with accompanying slides.
Keynote Address: Implications of the Patient Protection and Affordable Care Act for Hematologists
Speaker: Lawrence A. Solberg, PhD, MD
Mayo Clinic, Jacksonville, Florida
Biography: Dr Solberg is a consultant in hematology in the Division of Hematology-Oncology at Mayo Clinic in Florida (MCF). He currently serves as Chair for Clinical Research at MCF. He received his AB degree (1962) and PhD degree in Physiology (1971) at the University of California, Berkeley. He taught physiology and received an MD degree summa cum laude from St Louis University School of Medicine in 1975. From 1975-1980 he trained in Internal Medicine and then Hematology at Mayo Clinic in Rochester, Minnesota. From 1980-1982 he served at Wright-Patterson Air Force Base in the USAF Medical Corps. He joined the Mayo Clinic staff in 1982 and has remained with this organization through the present, transferring to the MCF campus in 1991. His research interest was in thrombopoietin and he was the Mayo PI working with Genentech in work that culminated with the cloning of Mpl-ligand as reported in Nature in 1994.
He has been engaged significantly in administrative positions within and outside of the Mayo Clinic. He initiated the autologous bone marrow transplant program in Rochester, Minnesota, in 1987 and established the bone marrow transplant program at MCF in 1992, serving as its director until 2004. This is now a joint program with Nemours Children’s Clinic in Jacksonville, Florida. He served as chair of the Division of Hematology-Oncology at MCF from 1991-2001. He has had an interest in and has served on various enterprise groups at Mayo Clinic in the information technology domain, including current service on the Mayo-IBM Oversight Committee and the Clinical Trials Management System Committee. He has also been active in helping to establish the Mayo Clinic Comprehensive Cancer Center at MCF.
Experience outside the Mayo Clinic has included service as Chair of the Community Hospice of Northeast Florida (CHNE) Board of Directors for 6 years through 2010. CHNE is one of the largest nonprofit hospices in the United States, caring for 1000 people a day including 50-100 children in 5 counties of northeast Florida. He also serves extensively within the American Society of Hematology. From 2004 he has been a member of the Clinical Practice Committee and has been Chair of that committee since 2008. He also serves on the Education Committee, the Government Affairs Committee, the Program Committee, and as a non-voting member of the ASH executive committee.
Dr Solberg is an author of the new ASH Clinical Guideline Update on ITP published recently.